The conference focused on discussing the latest technologies in the preclinical, translational neuroscience space and also new innovations happening in translational neuroscience imaging.
Paul Karila, CSO & Director, chronic pain research, gave a presentation on Oct 4, 2018 titled:
Novel approaches and concepts for development of functional in vitro assays targeting neurodegenerative disease discovery
The talk covered:
- Combining primary and stem cell-derived neuronal cell cultures with optical electrophysiology to produce complex assays for functional screening
- Microsystems engineering approaches for generation of compartmentalized cell cultures for high capacity screening
- Multiparametric data analysis of combined optical electrophysiology and high content imaging data to cover both functional and morphological aspects of disease
Contact us to learn more
If you missed the event and would like to learn more about Cellectricon and our CNS disease research, you are welcome to contact us.